Page last updated: 2024-08-24

ursolic acid and MS (Multiple Sclerosis)

ursolic acid has been researched along with MS (Multiple Sclerosis) in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Chen, WJ; Ciric, B; Curtis, MT; Li, X; Rostami, A; Zhang, GX; Zhang, Y	1
Iwasa, K; Maruyama, K; Sakemoto, C; Shimizu, K; Yamamoto, S; Yoshikawa, K	1

Other Studies

2 other study(ies) available for ursolic acid and MS (Multiple Sclerosis)

Article	Year
A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proceedings of the National Academy of Sciences of the United States of America, 2020, 04-21, Volume: 117, Issue:16 Topics: Animals; Astrocytes; Cell Differentiation; Corpus Callosum; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Immunomodulation; Male; Mice; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; PPAR gamma; Remyelination; Triterpenes; Ursolic Acid	2020
Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. Journal of pharmacological sciences, 2020, Volume: 144, Issue:3 Topics: Administration, Oral; Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression; Insulin-Like Growth Factor I; Mice; Motor Activity; Multiple Sclerosis; Triterpenes; Up-Regulation; Ursolic Acid	2020

Article

Year

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 04-21, Volume: 117, Issue:16

Topics: Animals; Astrocytes; Cell Differentiation; Corpus Callosum; Cuprizone; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Immunomodulation; Male; Mice; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; PPAR gamma; Remyelination; Triterpenes; Ursolic Acid

2020

Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1.

Journal of pharmacological sciences, 2020, Volume: 144, Issue:3

Topics: Administration, Oral; Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression; Insulin-Like Growth Factor I; Mice; Motor Activity; Multiple Sclerosis; Triterpenes; Up-Regulation; Ursolic Acid

2020